Startup Spotlight: LetsGetChecked plans home COVID-19 tests
Founded in 2015, LetsGetChecked is an at-home testing platform based in New York, with services available in the United States, Canada, and Europe.
Offering a wide variety of tests in areas such as sexual health, men and women’s health and wellness, tests are delivered and returned to the lab with a prepaid shipping label, before confidential results are accessible via an online account within 2-5 days. The company says it has performed over 450,000 tests into areas such as diabetes, cholesterol, and thyroid testing; cancer screening, sexual health testing, fertility testing, and pharmacogenomic testing, and that it serves 28 markets.
The company’s approach has won it financial backing, with $113mn raised across three funding rounds. Its latest Series C round raised $71mn, led by Illumina Ventures and HLM Venture Partners, with other participants including Deerfield, CommonFund Capital, and Angeles Investments. Existing investors Transformation Capital, Optum Ventures, and Qiming Venture Partners USA.
The company is planning to bring its tests for COVID-19 to the public at some point, having already become available for frontline healthcare workers in the United States.
"We have been developing our platform for more than five years and have helped hundreds of thousands of individuals by enabling access to high-quality testing and telehealth services in the home, across many health conditions. With the onset of COVID-19, we realigned resources with a view to helping with this global pandemic and are currently delivering tens of thousands of tests per day to critical and frontline healthcare workers", said LetsGetChecked founder and CEO Peter Foley in a press release.
"We are working hard to deliver COVID-19 testing into the home and hope to have an answer soon. At-home testing has never been more important as consumers around the world look for new and trusted methods for managing their health."
- Flo Sets New Standards for Data Protection in Health TechTechnology & AI
- GE Healthcare: Defining the Future of Healthcare TechnologyTechnology & AI
- Dexcom’s €300m European Diabetes Technology DevelopmentMedical Devices & Pharma
- Johnson & Johnson: 138 Years of Pioneering HealthcareMedical Devices & Pharma